Article Details
Retrieved on: 2025-01-08 22:23:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Eligible patients had prior exposure to a proteasome inhibitor, immunomodulator, and anti-CD38 monoclonal antibody. Patients with extramedullary ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here